Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Having both diabetes, CAD increases risk for dementia
Patients with both diabetes and CAD appeared at significantly greater risk for dementia, especially vascular dementia, according to study findings published in European Journal of Preventive Cardiology.
Q&A: Blood-based biomarker testing ‘scientific consensus favorite’ for AD detection
Earlier this year, the FDA granted breakthrough device designation to Quanterix for its blood-based diagnostic assay to aid in the diagnosis of Alzheimer’s disease.
Log in or Sign up for Free to view tailored content for your specialty!
Neurologists mired in ‘wait and see’ approach to Leqembi prescription, administration
The FDA’s approval of Leqembi in July 2023 triggered a wave of discussion in the medical community on how to prescribe and properly administer the amyloid-targeting antibody to treat those diagnosed with Alzheimer’s disease.
Lithium in drinking water linked to negative effects on human health
NEW YORK — Lithium exposure in drinking water was associated with potentially detrimental effects on human health, including increased risk for autism spectrum disorder and schizophrenia spectrum disorder, according to researchers.
Novel receptor agonist linked to significant improvement in Alzheimer’s-related agitation
DENVER — Treatment with a novel, oral receptor agonist led to rapid and significant improvements in those with agitation related to Alzheimer’s disease, according to a speaker at the American Academy of Neurology annual meeting.
Labcorp, Quest Diagnostics add to roster of blood-based biomarker testing for Alzheimer’s
Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for Alzheimer’s disease, one which detects glial fibrillary acidic protein and another for phosphorylated tau.
Midlife heart health potential risk factor for early cognitive decline in Black women
Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers reported.
FDA grants breakthrough device designation to blood-based Alzheimer’s biomarker assay
The FDA has granted breakthrough device designation to a blood-based biomarker test to more quickly detect amyloid presence in individuals with suspected Alzheimer’s disease, according to the manufacturer.
Abrupt-onset dementia rare, may be treatable with prompt recognition
DENVER — While rare and associated with a limited differential diagnosis, abrupt-onset dementia may be treatable with prompt recognition and early intervention, according to a poster at the American Academy of Neurology annual meeting.
Neighborhood not associated with subjective cognitive decline in Black women
DENVER – Location of residence was not associated with subjective cognitive decline in Black women, suggesting the Area Deprivation Index may not be a reliable measurement, according to a speaker.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read